Y-mAbs Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Y-mAbs Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.16 USD/shares, a 11.1% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.54 USD/shares, a 20% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.49 USD/shares, a 77.6% increase from 2022.
  • Y-mAbs Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.19 USD/shares, a 71.1% decline from 2021.
  • Y-mAbs Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.28 USD/shares, a 56.9% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 +$1.70 +77.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$2 -$1 -71.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$1 +$1.69 +56.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$3 -$1 -29.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$2 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.